[go: up one dir, main page]

UY31584A1 - Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, su uso y el medicamento que lo contiene - Google Patents

Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, su uso y el medicamento que lo contiene

Info

Publication number
UY31584A1
UY31584A1 UY31584A UY31584A UY31584A1 UY 31584 A1 UY31584 A1 UY 31584A1 UY 31584 A UY31584 A UY 31584A UY 31584 A UY31584 A UY 31584A UY 31584 A1 UY31584 A1 UY 31584A1
Authority
UY
Uruguay
Prior art keywords
steroid
carboxilico
hidroxi
acid
product containing
Prior art date
Application number
UY31584A
Other languages
English (en)
Inventor
Thomas Frenzel
Frederik Menges
Jan Huebner
Hans-Peter Muhn
Steffen Borden
Katja Prelle
Sven Ring
Rolf Bohlmann
Ulrich Klar
Joachim Kuhnke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31584A1 publication Critical patent/UY31584A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Derivados de y-lactona del esteroide del ácido 17-hidroxi-19-no-21-carboxílico de la formula química I, donde Z se selecciona del grupo que comprende oxígeno, des átomos de hidrogeno, NOR`y NNHSO2R, donde R` es hidrogeno, C1-C10-alquilo, arilo o C7-C20-aralquilo, R4 se selecciona del grupo que comprende hidrogeno y halogeno.
UY31584A 2007-12-29 2008-12-26 Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, su uso y el medicamento que lo contiene UY31584A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063503A DE102007063503A1 (de) 2007-12-29 2007-12-29 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
UY31584A1 true UY31584A1 (es) 2009-08-03

Family

ID=40481980

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31584A UY31584A1 (es) 2007-12-29 2008-12-26 Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, su uso y el medicamento que lo contiene

Country Status (22)

Country Link
US (1) US8937058B2 (es)
EP (1) EP2238151A1 (es)
JP (1) JP5600068B2 (es)
KR (1) KR20100102688A (es)
CN (1) CN101910190A (es)
AR (1) AR069966A1 (es)
AU (1) AU2008342910A1 (es)
BR (1) BRPI0821922A2 (es)
CA (1) CA2710491C (es)
CL (1) CL2008003918A1 (es)
CO (1) CO6300845A2 (es)
CR (1) CR11545A (es)
DE (1) DE102007063503A1 (es)
DO (1) DOP2010000198A (es)
EC (1) ECSP10010318A (es)
IL (1) IL206379A0 (es)
PA (1) PA8809701A1 (es)
PE (1) PE20091362A1 (es)
TW (1) TW200940073A (es)
UY (1) UY31584A1 (es)
WO (1) WO2009083266A1 (es)
ZA (1) ZA201005396B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US3194803A (en) * 1960-04-28 1965-07-13 Searle & Co Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3426771C2 (de) 1984-07-07 1997-03-20 Schering Ag 13alpha-Methylgonane, deren Herstellung und Verwendung
DE4232521A1 (de) 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Also Published As

Publication number Publication date
ECSP10010318A (es) 2010-08-31
US8937058B2 (en) 2015-01-20
AR069966A1 (es) 2010-03-03
CR11545A (es) 2010-08-27
CO6300845A2 (es) 2011-07-21
CA2710491C (en) 2015-11-03
JP5600068B2 (ja) 2014-10-01
AU2008342910A1 (en) 2009-07-09
IL206379A0 (en) 2010-12-30
PA8809701A1 (es) 2009-07-23
WO2009083266A1 (de) 2009-07-09
CA2710491A1 (en) 2009-07-09
PE20091362A1 (es) 2009-10-15
ZA201005396B (en) 2012-01-25
TW200940073A (en) 2009-10-01
EP2238151A1 (de) 2010-10-13
KR20100102688A (ko) 2010-09-24
CN101910190A (zh) 2010-12-08
DOP2010000198A (es) 2010-08-31
DE102007063503A1 (de) 2009-07-02
US20110021472A1 (en) 2011-01-27
CL2008003918A1 (es) 2010-01-15
JP2011507924A (ja) 2011-03-10
BRPI0821922A2 (pt) 2015-06-16

Similar Documents

Publication Publication Date Title
CY1119780T1 (el) Παραγωγα πυραζολινοδιονης σαν αναστολεις της οξειδασης nadph
CY1115952T1 (el) Παραγωγα πυραζολο πυριδινης σαν αναστολεις της οξειδασης nadρη
DOP2011000361A (es) Nuevos derivados de pirimidina y sus usos en el tratamiento del cancer y otras enfermedades
CO6361937A2 (es) Derivados de heteroaril amidas y sus usos como activadores de glucoquinasa
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
ATE542531T1 (de) Nitrofuran-verbindungen zur behandlung von krebs und angiogenese
UA107951C2 (xx) Похідні імідазопіридину як інгібітори jak
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
UY30547A1 (es) Derivados n-sustituidos de la 6-piridin-4-il quinazolin-2-amina, sus estereoisomeros y sales farmacéuticamente aceptables, proceso de preparacion, composiciones y aplicaciones.
UY32644A (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
CU20100032A7 (es) Depsipéptidos cíclicos
UY31689A1 (es) Derivados de platino-carbeno n-heterocíclico, su preparación y su aplicación en terapéutica
DOP2010000389A (es) Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos b2 para el tratamiento de trastornos respiratorios
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
ECSP11011369A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad glucocorticoide
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
UA97965C2 (ru) Замещенные пиразолы, содержащая их композиция, способ их получения и применения
PA8793101A1 (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung
UY31584A1 (es) Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, su uso y el medicamento que lo contiene
UY31583A1 (es) Derivado de y-lactona de esteroide de acido 15, 16-metilen-17-hidroxi-19-nor-21-carboxilico, su uso y medicamento que lo contiene.
UY31581A1 (es) Derivado 15, 16-metilen-17-(1' - propenil)-17-3' -oxidoestra-4-en-3-ona, su uso y medicamento que lo contiene
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
UA98834C2 (ru) 19-НОР-СТЕРОИДНЫЕ ПРОИЗВОДНЫЕ С 15α,16α-МЕТИЛЕНОВОЙ ГРУППОЙ И НАСЫЩЕННЫМ 17,17-СПИРОЛАКТОНОВЫМ КОЛЬЦОМ, ИХ ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННОЕ СРЕДСТВО, КОТОРОЕ СОДЕРЖИТ ЭТИ ПРОИЗВОДНЫЕ

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20171024